Clinical Trial Update: A Study to Investigate the Effect of AZD0780 Tablets in Combination With Rosuvastatin Tablets on Low Density Lipoprotein Cholesterol Levels (LDL-C) in Adult Participants With Dyslipidaemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial to evaluate the effect of AZD0780 in combination with rosuvastatin on LDL cholesterol in adults with dyslipidemia; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• AZD0780
• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: AstraZeneca | Conditions: Dyslipidaemia | Phase 2 | Status: RECRUITING